# Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating

> **NCT01671800** · PHASE1 · COMPLETED · sponsor: **Henry M. Jackson Foundation for the Advancement of Military Medicine** · enrollment: 20 (actual)

## Conditions studied

- Hyperhidrosis

## Interventions

- **DRUG:** Botulinum Type B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01671800
- **Lead sponsor:** Henry M. Jackson Foundation for the Advancement of Military Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01671800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01671800, "Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01671800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*